课题基金 / 基金详情

项目摘要

项目成果

Lynn Jorde的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this renewal, we will continue our studies of the causes and disease consequences of human genetic variation. We have generated whole-genome sequence (WGS) data from the three-generation Utah CEPH pedigrees to longitudinally characterize rates and patterns of de novo mutations (DNMs). We showed significant differences in the rates of accumulation of mutations among families, and we demonstrated that 10% of apparent DNMs are actually postzygotic events that result in mosaicism. We also showed that a higher rate of age-adjusted germline DNM transmission is significantly associated with a shorter lifespan and earlier menopause. These results imply that one’s germline DNM rate, which increases with age, is associated with the somatic mutation rate. In the next funding period, we will test this hypothesis directly using blood-derived DNA samples collected at three different time points in the same CEPH pedigree members over a 35-year time period. To our knowledge, this is the first long-term longitudinal study of germline and somatic mutation rates in human pedigrees. We also hypothesize that DNA repair mechanisms influence variation in both germline and somatic mutation rates. We will test this hypothesis using whole-genome sequence data (supported by separate funding) and RNA-seq data from freshly collected whole blood samples. We predict that lower expression of critical DNA repair genes will result in higher germline and somatic mutation rates. To increase our power to detect patterns and disease associations, we will (under separate funding) expand the CEPH pedigree collection to include more than 700 members of the fourth generation, who are now adults. We will also resample generations 2 and 3 for a third time. We will undertake WGS and RNA-seq in these study participants, creating a unique, publicly available repository of genetic information spanning four generations. More than 180 phenotypic measurements were made for generations 2 and 3 of the CEPH pedigrees 20 years ago, and the same measurements will be made for generation 4. These resources will allow us to explore the effects of genetic variation, including mutation rates and DNA repair, on a broad assortment of phenotypes across several generations. In addition, we will continue our work to develop new and improved methods for genome sequence analysis, including the detection of mobile element insertions. We will analyze WGS and RNA-seq data from members of large Utah disease pedigrees obtained from the Utah Population Database, focusing on amyotrophic lateral sclerosis and juvenile idiopathic arthritis. These projects involve analysis of WGS and RNA-seq data as well as functional analysis in in vitro and in vivo systems.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.ab.2019.113516
发表时间: 2020-03-15
期刊: ANALYTICAL BIOCHEMISTRY
影响因子: 2.9
作者: [Storer, Jessica M., Walker, Jerilyn A., Batzer, Mark A.]
通讯作者: Batzer, Mark A.
DOI: 10.1186/s12859-018-2056-y
发表时间: 2018-02-20
期刊: BMC bioinformatics
影响因子: 3
作者: [Flygare S, Hernandez EJ, Phan L, Moore B, Li M, Fejes A, Hu H, Eilbeck K, Huff C, Jorde L, G Reese M, Yandell M]
通讯作者: Yandell M
DOI: 10.1001/jama.2020.0517
发表时间: 2020-03-17
期刊: JAMA
影响因子: --
作者: [Jorde LB, Bamshad MJ]
通讯作者: Bamshad MJ
DOI: 10.1186/s12864-017-3767-6
发表时间: 2017-05-22
期刊: BMC genomics
影响因子: 4.4
作者: [Rustagi N, Zhou A, Watkins WS, Gedvilaite E, Wang S, Ramesh N, Muzny D, Gibbs RA, Jorde LB, Yu F, Xing J]
通讯作者: Xing J
6
    Human Genetic Variation and Disease
    • 批准号:
      10206753
    • 项目类别:
    • 资助金额:
      $60.49万
    • 财政年份:
      2016
    • 负责人:
      Lynn Jorde
    • 依托单位:
    Human Genetic Variation and Disease
    • 批准号:
      10431948
    • 项目类别:
    • 资助金额:
      $58.3万
    • 财政年份:
      2016
    • 负责人:
      Lynn Jorde
    • 依托单位:
    Training Program in Genomic Medicine
    • 批准号:
      10632018
    • 项目类别:
    • 资助金额:
      $30.53万
    • 财政年份:
      2016
    • 负责人:
      Lynn Jorde
    • 依托单位:
    Training Program in Genomic Medicine
    • 批准号:
      10415080
    • 项目类别:
    • 资助金额:
      $32.48万
    • 财政年份:
      2016
    • 负责人:
      Lynn Jorde
    • 依托单位:
    国内基金
    海外基金
    补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
    靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
    • 批准号:
      JCZRQN202500010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
    • 批准号:
      2025JJ70209
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      雷芬芳
    • 依托单位:
    AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      万荣
    • 依托单位: